First-Line Antibiotics for Acute Bacterial Tonsillitis

Primary Treatment Options

Penicillin is the first-line antibiotic treatment for acute bacterial tonsillitis due to its proven efficacy, safety, narrow spectrum, and low cost, as recommended by the Infectious Diseases Society of America 1
Penicillin V (oral) is the first-choice treatment for acute bacterial tonsillitis, particularly effective against Group A β-hemolytic streptococci (GABHS), the most common bacterial cause, according to the American Academy of Pediatrics 1
Amoxicillin is often used in younger children instead of penicillin V due to better taste acceptance and availability as syrup/suspension, as suggested by the American Academy of Family Physicians 1

Clindamycin is the preferred alternative for penicillin-allergic patients with excellent gram-positive coverage against Streptococcus pyogenes, as recommended by the American College of Physicians 2
First-generation cephalosporins are a good alternative in non-Type I penicillin allergies, according to the Infectious Diseases Society of America 3
Macrolides (azithromycin, clarithromycin, erythromycin) are options for patients with true penicillin allergy, though with lower efficacy rates (77-78%) compared to first-line options, as reported by the American Academy of Otolaryngology-Head and Neck Surgery 4

For children, high-dose amoxicillin (90 mg/kg/day) or amoxicillin-clavulanate (90 mg/6.4 mg per kg/day) is recommended by the American Academy of Pediatrics 4

If no improvement after 72 hours of initial therapy, consider switching antibiotics, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 4
For treatment failures with penicillin, clindamycin (20-30 mg/kg/day in 3 doses, maximum 300 mg/dose) is an alternative option, as recommended by the American College of Physicians 2

Amoxicillin should be avoided in children with suspected Epstein-Barr virus infection due to risk of severe rash, as warned by the American Academy of Pediatrics 1
Group A β-hemolytic streptococci have not developed resistance to penicillins over five decades, according to the Infectious Diseases Society of America 1
Combination therapy may be considered in severe or recurrent cases (e.g., clindamycin plus rifampin), as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 4

Using broad-spectrum antibiotics unnecessarily when narrow-spectrum options would be effective, as cautioned by the Infectious Diseases Society of America 1
Overlooking the possibility of a carrier state rather than active infection in recurrent cases, as noted by the American College of Physicians 2

Reassess patients who don't respond to initial therapy within 72 hours, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 4
Consider further evaluation with cultures if symptoms persist despite appropriate second-line therapy, as suggested by the American College of Physicians 2

The American College of Physicians recommends only treating with antibiotics if Group A streptococcal infection is confirmed by rapid antigen detection test or throat culture, with key clinical features including persistent fever, anterior cervical adenitis, tonsillopharyngeal exudates, and absence of cough 5, 6
The American Academy of Family Physicians suggests providing analgesic therapy regardless of antibiotic decision, including acetaminophen, ibuprofen, aspirin, or throat lozenges, with pain management addressed immediately, especially during the first 24 hours 5, 6, 7
The Infectious Diseases Society of America recommends against prescribing antibiotics for viral pharyngitis, which accounts for the majority of sore throat cases, and against using broad-spectrum antibiotics unnecessarily when narrow-spectrum penicillin would be effective 5, 6, 8

The European Society of Clinical Microbiology and Infectious Diseases found that 10-day courses of antibiotics are more effective than shorter durations, with a 2023 meta-analysis showing that 5-day courses of standard-dose penicillin are less effective for Group A streptococcal pharyngitis (OR 0.43; 95% CI 0.23-0.82) 8
The American Academy of Pediatrics recommends reassessing patients at 72 hours if no improvement or worsening symptoms, and considering switching to clindamycin if initial penicillin therapy fails 5, 6

The Centers for Disease Control and Prevention note that Group A β-hemolytic streptococci have not developed resistance to penicillins over five decades, making penicillin remain highly effective, with the primary benefits of antibiotic therapy being prevention of suppurative complications and spread of infection, not symptom relief 5, 6

A full 10‑day oral antibiotic course is required to achieve maximal pharyngeal eradication of Group A Streptococcus in acute bacterial tonsillitis. 9
Shorter 5‑day regimens have been investigated but result in significantly lower bacteriologic eradication rates compared with the standard 10‑day schedule. 9
Ensuring patient adherence to the complete 10‑day course (whether penicillin V or a macrolide) is essential, because incomplete therapy markedly increases the risk of bacteriologic failure. 9

Co‑amoxiclav (amoxicillin/clavulanate) should be reserved for cases of recurrent tonsillitis, documented treatment failures, or when beta‑lactamase‑producing organisms are suspected; it is not recommended for routine first‑line therapy in non‑exudative tonsillitis. 9